The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. [electronic resource]
- Pharmacology & therapeutics Oct 2008
- 54-70 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0163-7258
10.1016/j.pharmthera.2008.07.004 doi
Animals Anti-Arrhythmia Agents--therapeutic use Arrhythmias, Cardiac--drug therapy Humans KATP Channels--antagonists & inhibitors Myocardium--metabolism Potassium Channel Blockers--therapeutic use Sarcolemma--drug effects